Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Europe bans drugs tested by GVK; FDA monitors but keeps allowing sales

The US FDA has found no systemic issues affecting the safety or efficacy of generics clinically tested at GVK BioSciences, but says it supports Europe’s ban of around 700 products.

The USDA said a goat and rabbits were mistreated at Santa Cruz Biotechnology

Slowly but surely... CROs gradually shifting to paperless trials, says Veeva

Clinical trial operators are slowly converting to electronic Trial Master Files (eTMFs) but almost a third still rely on paper to manage data, according to cloud-based software provider Veeva.

WuXi enters strategic lab testing partnership with HK-based firm

WuXi PharmaTech has signed a strategic partnership deal to provide exclusive laboratory testing services to Hong Kong-headquartered Lee’s Pharmaceutical.

UK clears first use of e-consent tech in clinical trial

A drugmaker trialling an autoimmune disease treatment in the UK has become the first cleared to use electronic informed consent by the National Health Service (NHS).

Hepalink adding biologics CDMO Cytovance in $200m acquisition

API supplier Hepalink will buy Cytovance for $206m (€183m) in a deal the biologics CDMO says will help expedite its expansion plans.

Shire to use new suppliers to up production of HAE drug filtered from US plasma

Shire will use contractors to increase production of Cinryze, the half billion dollar-a-year Hereditary Angioedema (HAE) drug it bought with ViroPharma in 2014.   

Key Industry Events


Access all events listing

Our events, Shows & Conferences...